Michael Ashton
Papers
1
Total Citations
31
H-Index
1
About
Dr. Michael Ashton is a leading figure in pharmaceutical bioanalysis and antimalarial drug development, with a career dedicated to advancing quantitative methods for monitoring drug exposure in resource-limited settings. His most cited work, the 2005 paper on developing an automated solid-phase extraction and liquid chromatographic method for piperaquine in urine (31 citations), exemplifies his core contribution: creating robust, cost-effective analytical techniques that enable therapeutic drug monitoring without requiring complex infrastructure. This method significantly improved the feasibility of pharmacokinetic studies for piperaquine—a critical component of artemisinin-based combination therapies—by simplifying sample preparation and analysis. Dr. Ashton’s research has directly supported global malaria control efforts by providing reliable tools to assess drug adherence, optimize dosing regimens, and evaluate treatment outcomes. His work bridges the gap between laboratory innovation and field application, ensuring that high-quality bioanalytical data can be generated even in challenging environments. Through these contributions, he has helped shape modern approaches to antimalarial drug development and public health surveillance.
Research Focus
Key Achievements
Top Papers
- 1